ScholarLens Back to search
2006•Journal of Internal Intensive MedicineRequires access

Value of Metoprolol in Treatment of Chronic Heart Failure: Clinical Observation of 60 Cases

Liu Shul

Open publisher page 0 citations

Abstract

Objective: To observe the therapeutic effect of metoprolol in patients with chronic heart failure (CHF). Methods:Sixty patients with CHF were selected randomly. The patients were divided into metoprolol group (34 cases, 6.25 -25 mg, bid or tid) and control group (26 cases).The efficacy of metoprolol on patient's symptoms and heart function were observed 6 months after treatment.Results: Left ventricular ejection was increased (50% ±2% vs 43%±1%,P 0.01 ) and left ventricular systolic volume was decreased ( 133.0 ±58 vs 141.2 ±55,P 0.01 ) in metoprolol group than those in the control group.Left ventricular end-diastolic volume decreased in metoprolol group compared with that of at baseline(P 0.05 ). Conclusion: On the basis of routine therapy, metoprolol can improve the symptoms and heart function significantly in patients with CHF.

About this research paper

What this paper is about

Objective: To observe the therapeutic effect of metoprolol in patients with chronic heart failure (CHF). Methods:Sixty patients with CHF were selected randomly. The patients were divided into metoprolol group (34 cases, 6.25 -25 mg, bid or tid) and control group (26 cases).The efficacy of metoprolol on patient's symptoms and heart function were observed 6 months after treatment.Results: Left ventricular ejection was increased (50% ±2% vs 43%±1%,P 0.01 ) and left ventricular systolic volume was decreased ( 133.0 ±58 vs 141.2 ±55,P 0.01 ) in metoprolol group than those in the control group.Left ventricular end-diastolic volume decreased in metoprolol group compared with that of at baseline(P 0.05 ). Conclusion: On the basis of routine therapy, metoprolol can improve the symptoms and heart function significantly in patients with CHF.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: To observe the therapeutic effect of metoprolol in patients with chronic heart failure (CHF). Methods:Sixty patients with CHF were selected randomly. The patients were divided into metoprolol group (34 cases, 6.25 -25 mg, bid or tid) and control group (26 cases).The efficacy of metoprolol on patient's symptoms and heart function were observed 6 months after treatment.Results: Left ventricular ejection was increased (50% ±2% vs 43%±1%,P 0.01 ) and left ventricular systolic volume was decreased ( 133.0 ±58 vs 141.2 ±55,P 0.01 ) in metoprolol group than those in the control group.Left ventricular end-diastolic volume decreased in metoprolol group compared with that of at baseline(P 0.05 ). Conclusion: On the basis of routine therapy, metoprolol can improve the symptoms and heart function significantly in patients with CHF.

Key concepts: Metoprolol, Medicine, Cardiology, Heart failure, Internal medicine, Ejection fraction, Anesthesia

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Value of Metoprolol in Treatment of Chronic Heart Failure: Clinical Observation of 60 Cases — Research Paper | ScholarLens